Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 396

1.

Outcomes of repeat cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for the treatment of peritoneal surface malignancy.

Votanopoulos KI, Ihemelandu C, Shen P, Stewart JH, Russell GB, Levine EA.

J Am Coll Surg. 2012 Sep;215(3):412-7. doi: 10.1016/j.jamcollsurg.2012.04.023. Epub 2012 May 26.

2.

Repeated cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in peritoneal carcinomatosis from appendiceal cancer: analysis of survival outcomes.

Sardi A, Jimenez WA, Nieroda C, Sittig M, Macdonald R, Gushchin V.

Eur J Surg Oncol. 2013 Nov;39(11):1207-13. doi: 10.1016/j.ejso.2013.08.017. Epub 2013 Sep 2.

PMID:
24007834
3.

Repeat Cytoreductive Surgery and HIPEC for Peritoneal Surface Malignancy and Peritoneal Carcinomatosis.

Wong JF, Tan GH, Wang W, Soo KC, Teo MC.

World J Surg. 2015 Jun;39(6):1578-83. doi: 10.1007/s00268-015-2986-8.

PMID:
25651962
4.

Iterative cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for recurrent peritoneal metastases.

Chua TC, Quinn LE, Zhao J, Morris DL.

J Surg Oncol. 2013 Aug;108(2):81-8. doi: 10.1002/jso.23356. Epub 2013 Jun 5.

PMID:
23737041
5.

Obesity and peritoneal surface disease: outcomes after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for appendiceal and colon primary tumors.

Votanopoulos KI, Swords DS, Swett KR, Randle RW, Shen P, Stewart JH, Levine EA.

Ann Surg Oncol. 2013 Nov;20(12):3899-904. doi: 10.1245/s10434-013-3087-2. Epub 2013 Jun 26.

6.

Iterative procedures combining cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for peritoneal recurrence: postoperative and long-term results.

Golse N, Bakrin N, Passot G, Mohamed F, Vaudoyer D, Gilly FN, Glehen O, Cotte E.

J Surg Oncol. 2012 Aug 1;106(2):197-203. doi: 10.1002/jso.23062. Epub 2012 Feb 13.

PMID:
22331814
7.

Intraperitoneal chemotherapy for peritoneal surface malignancy: experience with 1,000 patients.

Levine EA, Stewart JH 4th, Shen P, Russell GB, Loggie BL, Votanopoulos KI.

J Am Coll Surg. 2014 Apr;218(4):573-85. doi: 10.1016/j.jamcollsurg.2013.12.013. Epub 2013 Dec 21.

8.

Outcomes of Cytoreductive Surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) in patients older than 70 years; survival benefit at considerable morbidity and mortality.

Votanopoulos KI, Newman NA, Russell G, Ihemelandu C, Shen P, Stewart JH, Levine EA.

Ann Surg Oncol. 2013 Oct;20(11):3497-503. doi: 10.1245/s10434-013-3053-z. Epub 2013 Jun 19.

9.

Peritoneal surface disease (PSD) from appendiceal cancer treated with cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC): overview of 481 cases.

Votanopoulos KI, Russell G, Randle RW, Shen P, Stewart JH, Levine EA.

Ann Surg Oncol. 2015 Apr;22(4):1274-9. doi: 10.1245/s10434-014-4147-y. Epub 2014 Oct 16.

10.

Secondary cytoreductive surgery and peri-operative intraperitoneal chemotherapy for peritoneal recurrence of colorectal and appendiceal peritoneal carcinomatosis following prior primary cytoreduction.

Klaver YL, Chua TC, Verwaal VJ, de Hingh IH, Morris DL.

J Surg Oncol. 2013 May;107(6):585-90. doi: 10.1002/jso.23303. Epub 2012 Dec 27.

PMID:
23280508
11.

Significance of urinary tract involvement in patients treated with cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC).

Votanopoulos KI, Randle RW, Craven B, Swett KR, Levine EA, Shen P, Stewart JH, Mirzazadeh M.

Ann Surg Oncol. 2014 Mar;21(3):868-74. doi: 10.1245/s10434-013-3354-2. Epub 2013 Nov 12.

12.

Secondary cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for recurrent epithelial ovarian cancer: a multi-institutional study.

Deraco M, Virzì S, Iusco DR, Puccio F, Macrì A, Famulari C, Solazzo M, Bonomi S, Grassi A, Baratti D, Kusamura S.

BJOG. 2012 Jun;119(7):800-9. doi: 10.1111/j.1471-0528.2011.03207.x.

13.
14.

Treatment of ovarian metastases of colorectal and appendiceal carcinoma in the era of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.

Kuijpers AM, Mehta AM, Aalbers AG, van Driel WJ, Boot H, Verwaal VJ.

Eur J Surg Oncol. 2014 Aug;40(8):937-42. doi: 10.1016/j.ejso.2014.02.238. Epub 2014 Feb 28.

PMID:
24630923
15.

Significance of diaphragmatic resections and thoracic chemoperfusion on outcomes of peritoneal surface disease treated with cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC).

Ahmed S, Levine EA, Randle RW, Swett KR, Shen P, Stewart JH, Votanopoulos KI.

Ann Surg Oncol. 2014 Dec;21(13):4226-31. doi: 10.1245/s10434-014-3891-3. Epub 2014 Jul 18.

16.
17.

Repeat cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for recurrent diffuse malignant peritoneal mesothelioma.

Huang Y, Alzahrani NA, Liauw W, Morris DL.

Eur J Surg Oncol. 2015 Oct;41(10):1373-8. doi: 10.1016/j.ejso.2015.07.004. Epub 2015 Jul 16.

PMID:
26227745
18.

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy improves the survival of gastric cancer patients with ovarian metastasis and peritoneal dissemination.

Wu XJ, Yuan P, Li ZY, Bu ZD, Zhang LH, Wu AW, Zong XL, Li SX, Shan F, Ji X, Ren H, Ji JF.

Tumour Biol. 2013 Feb;34(1):463-9. doi: 10.1007/s13277-012-0571-4. Epub 2012 Oct 30.

PMID:
23108893
19.

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in Asian patients: 100 consecutive patients in a single institution.

Teo MC, Tan GH, Tham CK, Lim C, Soo KC.

Ann Surg Oncol. 2013 Sep;20(9):2968-74. doi: 10.1245/s10434-013-2947-0. Epub 2013 Mar 17.

PMID:
23504144
20.

Quality of life in patients with peritoneal surface malignancies after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.

Chia CS, Tan WJ, Wong JF, Tan GH, Lim C, Wang W, Sin EI, Tham CK, Soo KC, Teo MC.

Eur J Surg Oncol. 2014 Aug;40(8):909-16. doi: 10.1016/j.ejso.2013.12.028. Epub 2014 Apr 13.

PMID:
24768445
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk